The pharmaceutical industry is rapidly changing with the growing popularity of biologics and biosimilars. In fact, more than 60 percent of patent filings are made on behalf of the industry’s top-ten biologics companies.1 Due to the effectiveness of biologics and biosimilars in treating and managing chronic conditions, biopharmaceuticals are seeing an annual growth rate of more than 8 percent, comprising 20 percent of the pharma market. 2
Published on